| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8827170 | Transplantation Proceedings | 2018 | 5 Pages |
Abstract
Induction immunosuppressive therapy with intravenous immunoglobulin and rituximab is effective; outcomes demonstrate an excellent patient and allograft survival and allograft function over the follow-up period.
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
S. Querido, A. Weigert, T. Adragão, J. Henriques, R. Birne, P. Matias, C. Jorge, C. Nascimento, M. Bruges, D. Machado,